| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $68,975,920 ) (Continued on the next page) |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL156986 | Angiotensin-(1-7) and Hypothalamic control of blood pressure | 000 | 5 | NIH | 4/11/2025 | $404,945 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL156986 | Angiotensin-(1-7) and Hypothalamic control of blood pressure | 001 | 5 | NIH | 7/16/2025 | $44,994 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | U01DK127384 | Data Coordinating Center for the Type 1 Diabetes in Acute Pancreatitis Consortium | 000 | 5 | NIH | 5/13/2025 | $600,000 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01CA260729 | Role of lncRNA mediated R-loops in CTCF boundary function and AML genome organization | 002 | 4 | NIH | 6/18/2025 | $62,636 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01CA260729 | Role of lncRNA mediated R-loops in CTCF boundary function and AML genome organization | 001 | 4 | NIH | 2/14/2025 | $0 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01CA260729 | Role of lncRNA mediated R-loops in CTCF boundary function and AML genome organization | 000 | 4 | NIH | 11/20/2024 | $563,725 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R35GM134864 | Nanoscale programing of celluar and physiological phenotypes | 002 | 6 | NIH | 4/18/2025 | $805,625 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01GM134681 | The role of DNA damage tolerance pathways in human cells | 000 | 6 | NIH | 4/22/2025 | $615,419 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01ES026184 | The Role of Mono-ADP-Ribosylation by PARP14 in Radioresistance | 001 | 9 | NIH | 1/28/2025 | $0 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01ES026184 | The Role of Mono-ADP-Ribosylation by PARP14 in Radioresistance | 000 | 9 | NIH | 1/6/2025 | $379,533 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS091299 | Translation dysregulation in neurodegeneration | 000 | 8 | NIH | 6/6/2025 | $707,634 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS136371 | Neuroanatomy and function of the ventral claustrum-dorsal endopiriform nucleus in mice | 000 | 1 | NIH | 1/24/2025 | $525,912 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS126448 | Using cryo-electron tomography and live-cell fluorescent imaging to study the role of cofilin in regulating neuronal filopodial structure and dynamics | 000 | 3 | NIH | 1/17/2025 | $357,869 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | UL1TR002014 | Penn State Clinical and Translational Science Institute | 000 | 9 | NIH | 8/5/2025 | $3,795,402 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | TL1TR002016 | J: Penn State NRSA Training Core | 000 | 9 | NIH | 8/5/2025 | $354,250 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | KL2TR002015 | I: Penn State Institutional Career Development Core | 000 | 9 | NIH | 8/5/2025 | $553,607 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HD088448 | iLookOut for Child Abuse: Microlearning to Improve Knowledge Retention | 000 | 10 | NIH | 8/12/2025 | $611,582 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R21AG093032 | Mechanisms underlying TDP-43 dependent structural deficits in ALS muscles | 000 | 1 | NIH | 4/25/2025 | $461,900 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS115942 | Poly-omic predictors of symptom duration and recovery for adolescent concussion | 001 | 5 | NIH | 3/13/2025 | $0 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS115942 | Poly-omic predictors of symptom duration and recovery for adolescent concussion | 000 | 5 | NIH | 12/24/2024 | $268,092 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL170140 | Angiotensin-(1-7) and Cardiovascular Derangements in Obesity Hypertension | 001 | 2 | NIH | 7/24/2025 | $71,970 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL170140 | Angiotensin-(1-7) and Cardiovascular Derangements in Obesity Hypertension | 000 | 2 | NIH | 3/28/2025 | $647,738 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | RM1MH138309 | Cross Scale Interrogation of NPD Genes (SING) in mice | 000 | 1 | NIH | 1/14/2025 | $3,498,931 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01CA222349 | Non-canonical Caspase-8 Activation on Autophagosomal Membranes | 003 | 7 | NIH | 5/21/2025 | $41,850 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01CA222349 | Non-canonical Caspase-8 Activation on Autophagosomal Membranes | 002 | 7 | NIH | 1/27/2025 | $376,650 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL173039 | SHePREG: Study of Heart function in PRE-Eclampsia during and after PreGnancy | 000 | 1 | NIH | 1/14/2025 | $1,274,927 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL173039 | SHePREG: Study of Heart function in PRE-Eclampsia during and after PreGnancy | 001 | 1 | NIH | 1/27/2025 | $9,454 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R21CA290500 | Stories to Prevent (StoP) HPV Cancers: A communication intervention to increase HPV vaccination among diverse populations | 000 | 1 | NIH | 3/25/2025 | $233,411 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | K08HL159314 | Abnormal Bleeding Risk in Female Hemophilia A Carriers | 000 | 5 | NIH | 8/14/2025 | $172,670 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01AI130156 | Analysis of the mechanism of HCMV cytoplasmic envelopment | 002 | 8 | NIH | 1/8/2025 | $472,949 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS119538 | Novel Targets and Therapeutic Interventions against Cerebral Ischemia-Reperfusion Injury | 000 | 5 | NIH | 5/30/2025 | $601,657 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R35GM147238 | Deciphering the progression and regulation of human translesion DNA synthesis | 000 | 4 | NIH | 5/1/2025 | $394,265 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS139128 | Mechanisms of cognitive impairment caused by atherosclerosis and red blood cell released ATP | 000 | 2 | NIH | 7/10/2025 | $650,715 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS139128 | Mechanisms of cognitive impairment caused by atherosclerosis and red blood cell released ATP | 000 | 2 | NIH | 7/10/2025 | $167,794 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01DK130992 | Glucose Management Clinical Decision Support to Improve Outcomes in Academic and Community Hospitals | 001 | 4 | NIH | 2/17/2025 | $0 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01DK130992 | Glucose Management Clinical Decision Support to Improve Outcomes in Academic and Community Hospitals | 000 | 4 | NIH | 11/22/2024 | $579,218 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | K23DK131290 | Establishing the mechanism of benefit and dose of exercise required to improve liver histology in patients with nonalcoholic steatohepatitis | 001 | 4 | NIH | 6/23/2025 | $0 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | K23DK131290 | Establishing the mechanism of benefit and dose of exercise required to improve liver histology in patients with nonalcoholic steatohepatitis | 000 | 4 | NIH | 11/22/2024 | $200,135 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL163585 | Impact of dilated cardiomyopathy mutations on cardiac myosin structure and function | 002 | 3 | NIH | 6/12/2025 | $0 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL163585 | Impact of dilated cardiomyopathy mutations on cardiac myosin structure and function | 001 | 3 | NIH | 11/25/2024 | $92,718 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL163585 | Impact of dilated cardiomyopathy mutations on cardiac myosin structure and function | 000 | 3 | NIH | 11/21/2024 | $614,075 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01GM127954 | Autophagosome closure by the ESCRT machinery | 000 | 8 | NIH | 8/1/2025 | $347,987 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R03AG081828 | Role of Y-family DNA polymerase Pol kappa in aging and Alzheimer's disease | 001 | 2 | NIH | 5/13/2025 | $166,800 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | F31EY037121 | Allosteric regulation of REDD1 as a therapeutic target for diabetic retinopathy | 003 | 1 | NIH | 6/18/2025 | $564 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | F31EY037121 | Allosteric regulation of REDD1 as a therapeutic target for diabetic retinopathy | 002 | 1 | NIH | 2/14/2025 | $0 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | F31EY037121 | Allosteric regulation of REDD1 as a therapeutic target for diabetic retinopathy | 000 | 1 | NIH | 11/15/2024 | $35,909 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | F31EY037121 | Allosteric regulation of REDD1 as a therapeutic target for diabetic retinopathy | 001 | 1 | NIH | 11/15/2024 | $0 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R35NS127217 | Deciphering Early Stages of Polyomavirus CNS Pathogenesis and Immunity | 000 | 4 | NIH | 5/1/2025 | $896,585 |
| | 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01AI162815 | Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1 | 001 | 5 | NIH | 6/6/2025 | $627,318 |
|
